News & Updates

Women with rheumatic diseases face adverse pregnancy outcomes
Women with rheumatic diseases face adverse pregnancy outcomes
09 Jun 2022 byJairia Dela Cruz

Pregnancies in women with rheumatic and systemic autoimmune diseases—including systemic lupus erythematosus, spondyloarthritis, and rheumatoid arthritis—pose significant health risks and are likely to lead to unfavourable outcomes, according to several studies presented at this year’s European Alliance of Associations for Rheumatology (EULAR) Congress.

Women with rheumatic diseases face adverse pregnancy outcomes
09 Jun 2022
Ectopic pregnancies resolve in around 20 days after methotrexate treatment
Ectopic pregnancies resolve in around 20 days after methotrexate treatment
31 May 2022

Methotrexate treatment helps resolve ectopic pregnancies after a median of 22 days, a recent study has found. Baseline levels of human chorionic gonadotrophin (hCG) may help predict the timing of resolution.

Ectopic pregnancies resolve in around 20 days after methotrexate treatment
31 May 2022